Cited by 90Salivary Gland Disorders and FunctionsT-cell and Retrovirus StudiesOcular Surface and Contact Lens

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

High prevalence of Sjögren's syndrome in patients with HTLV-I associated myelopathy

Open access
Nakamura, Hideki, Eguchi, Katsumi, Nakamura, Tatsufumi, Mizokami, Akinari, Shirabe, Susumu, Kawakami, Atsushi, Matsuoka, Naoki, Migita, Kiyoshi, Kawabe, Yojiro, Nagataki, Shigenobu·1997·Annals of the Rheumatic Diseases

Abstract

Objective A high seroprevalence of HTLV-I in female Sjögren's syndrome (SS) patients has been reported in Nagasaki, Japan, an area that is heavily endemic for HTLV-I infection. Salivary IgA class antibodies to HTLV-I were common among HTLV-I seropositive patients with SS. This study was undertaken to elucidate the pathogenesis of SS caused by HTLV-I infection. Methods The clinical features and histological findings of SS and the prevalence of serum autoantibodies in 10 patients with HTLV-I associated myelopathy (HAM) who were consecutively admitted into Nagasaki University School of Medicine, were compared with those of 20 HTLV-I seropositive and 20 HTLV-I seronegative patients with SS. Results Ocular and oral manifestations of SS were commonly detected in HAM patients. These patients also had extraglandular manifestations including recurrent uveitis, arthropathy, interstitial pneumonitis, Raynaud's phenomenon, and inflammatory bowel disease. All patients with HAM histologically showed a mononuclear cell infiltration in the labial salivary glands. Six of 10 patients had a mononuclear cell infiltration with a focus score of 1 or greater. According to the preliminary criteria for SS proposed by the European Community, definitive SS was diagnosed in six patients and probable SS in two patients. Serum gamma globulin and IgG values were increased in HAM patients. Patients with HAM had lower prevalence of rheumatoid factor, antinuclear antibody, and anti-SS-A (Ro) antibody than those of HTLV-I seropositive and HTLV-I seronegative SS patients. However, there was no significant difference in the prevalence of these antibodies among HAM patients with definitive SS, HTLV-I seropositive and HTLV-I seronegative SS patients. The CD3+CD4+ T cells preferentially infiltrated into the salivary glands in HAM patients as well as the salivary glands of patients with HTLV-I seropositive and seronegative patients. It seems probable that peripheral blood mononuclear cells from HAM patients preferentially infiltrated into the salivary glands, and that these cells produced the autoantibodies as well as anti-HTLV-I antibody. Conclusion The results strongly support the idea that HTLV-I is involved in the pathogenesis of the disease in a subset of patients with SS in endemic areas.

Overview

Integrity signals

Registry

Crossref · 10.1136/ard.56.3.167

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HTLV-1 infection is linked with an elevated rate of opportunistic infections, including uveitis, Sjögren's syndrome, infective dermatitis, bronchiectasis, and inflammatory disorders such as arthritis.

    “This includes uveitis [93], Sjögren’s syndrome [94], infective dermatitis [95], bronchiectasis [96], and inflammatory disorders such as arthritis [97], amongst others [11,97,98,99].”

    From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [94]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. Hinuma, 1981, Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera., Proc Natl Acad Sci USA, 78, 6476, 10.1073/pnas.78.10.6476 · DOI · Paper page
  2. Gessain, 1985, Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis., Lancet, ii, 407, 10.1016/S0140-6736(85)92734-5 · DOI
  3. Osame, 1986, HTLV-I associated myelopathy, a new clinical entity., Lancet, i, 1031, 10.1016/S0140-6736(86)91298-5 · DOI
  4. Gessain, 1990, High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis., Blood, 75, 428, 10.1182/blood.V75.2.428.428 · DOI · Paper page
  5. Prince, 1991, Immunologic correlates of spontaneous lymphocyte proliferation in human T-lymphotropic virus infection., Blood, 78, 169, 10.1182/blood.V78.1.169.169 · DOI
  6. Yoshida, 1989, Increased replication of HTLV-I in HTLV-I-associated myelopathy., Ann Neurol, 26, 331, 10.1002/ana.410260304 · DOI · Paper page
  7. Moutsopoulos, 1980, Sjögren's syndrome (sicca syndrome) current issues., Ann Intern Med, 92, 212, 10.7326/0003-4819-92-2-212 · DOI
  8. Garry, 1994, New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune disease., Arthritis Rheum, 37, 465, 10.1002/art.1780370405 · DOI
  9. Eguchi, 1992, Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features., Ann Rheum Dis, 51, 769, 10.1136/ard.51.6.769 · DOI
  10. Terada, 1994, Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome., Lancet, 344, 1116, 10.1016/S0140-6736(94)90630-0 · DOI
  11. Osame, 1987, Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T cell leukemia-like cells., Ann Neurol, 21, 117, 10.1002/ana.410210203 · DOI
  12. Vitali, 1993, Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by European Community., Arthritis Rheum, 36, 340, 10.1002/art.1780360309 · DOI
  13. World Health Organization, 1990, Acquired immunodeficiency syndrome (AIDS): proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II., Weekly Epidemiological Record, 65, 281
  14. DaSilva, 1995, Sex hormones, glucocorticoids and autoimmunity: facts and hypothesis., Ann Rheum Dis, 54, 6, 10.1136/ard.54.1.6 · DOI
  15. Mochizuki, 1992, HTLV-I uveitis: a distinct clinical entity caused by HTLV-I., Jpn J Cancer Res, 83, 236, 10.1111/j.1349-7006.1992.tb00092.x · DOI
  16. Nishioka, 1989, Chronic inflammatory arthropathy associated with HTLV-I., Lancet, i, 441, 10.1016/S0140-6736(89)90038-X · DOI
  17. Sugimoto, 1987, T-lymphocyte alveolitis in HTLV-I-associated myelopathy., Lancet, i, 1220, 10.1016/S0140-6736(87)91362-6 · DOI
  18. Vernant, 1988, T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren's syndrome., Lancet, i, 177, 10.1016/S0140-6736(88)92744-4 · DOI
  19. Ichinose, 1992, Increased adherence of T cells to human endothelial cells in patients with T-cell lymphotropic virus type I-associated myelopathy., Arch Neurol, 49, 74, 10.1001/archneur.1992.00530250078019 · DOI
  20. Bélec, 1994, Antibodies to HTLV-I in Sjögren's syndrome., Lancet, 345, 71
  21. Umehara, 1993, Immunohistochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy., J Neuropathol Exp Neurol, 52, 424, 10.1097/00005072-199307000-00010 · DOI
  22. Coll, 1993, Sicca syndrome associated with human immunodeficiency virus infection: an immunohistochemical study., Arthritis Rheum, 36, 875, 10.1002/art.1780360621 · DOI
  23. Miyoshi, 1992, Excretion of HTLV-I in saliva., JAMA, 267, 236, 10.1001/jama.1992.03480020046029 · DOI
  24. Pawlosky, 1995, Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes., Ann Intern Med, 122, 169, 10.7326/0003-4819-122-3-199502010-00002 · DOI
  25. Renjifo, 1995, Tax mutation associated with tropical spastic paraparesis/ human T-cell leukemia virus type I-associated myelopathy., J Virol, 69, 2611, 10.1128/jvi.69.4.2611-2616.1995 · DOI
  26. Niewiesk, 1994, The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis., J Virol, 68, 6778, 10.1128/jvi.68.10.6778-6781.1994 · DOI
  27. Flescher, 1991, Do viruses contribute to the development of Sjögren's syndrome ?, Am J Med, 90, 283, 10.1016/0002-9343(91)80006-8 · DOI
  28. Gallo, 1982, Human T-cell leukemia-lymphoma virus (HTLV-I) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma., Proc Natl Acad Sci USA, 79, 5680, 10.1073/pnas.79.18.5680 · DOI

Cited by

Sorted by citations

Metadata

Authors
Nakamura, H., Eguchi, K., Nakamura, T., Mizokami, A., Shirabe, S., Kawakami, A., Matsuoka, N., Migita, K., Kawabe, Y., & Nagataki, S.
Affiliations
Nagasaki University (JP)
Corresponding author
Nagataki, Shigenobu
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
1997-03
Volume
56
Issue
3
Pages
167
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2085195265
Cited by
90
References
1
Citations by year
2025: 1 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 3 · 2012: 3
FWCI
3.53
Type
journal article
Language
en
Open access
Locations
  • Annals of the Rheumatic Diseases (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Salivary Gland Disorders and Functions
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Health Sciences › Medicine › Ophthalmology › Ocular Surface and Contact Lens
Keywords
Sjögren's syndrome, HTLV-1, tropical spastic paraparesis, CD4+ T cells, autoantibodies, HTLV-I antibodies, extraglandular manifestations, uveitis, labial salivary glands, pathogenesis, Nagasaki
MeSH terms
Adult, Aged, Antibodies, Viral, Autoantibodies, Female, Humans, Japan, Male, Middle Aged, Rheumatoid Factor, Salivary Glands, Sjogren's Syndrome, Human T-lymphotropic virus 1, Paraparesis, Tropical Spastic, CD4 Antigens, Prevalence, Immunophenotyping, CD8 Antigens, CD3 Complex, Antigens, CD20

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review